Developments Our focus on heart valve disease management has expanded to include tissue valves, valve repair and coronary bypass connector products. This includes mechanical valve replacement, tissue valve replacement, and valve repair performed with or without a prosthesis. But the tissue valve segment is considered the fastest-growing portion of the total heart valve market. The valve is sutured directly into the aortic wall, with no sewing cuff or stent needed to help it retain its shape. This allows a much larger valve to be implanted for improved hemodynamics.
Valve repair is another growing market segment.
The ring's rigid anterior portion allows for annular remodeling, and its flexible posterior portion is designed to preserve the physiologic motion of the valve annulus during the cardiac cycle. European and U.S. implants are currently under way. These unique anastomotic technologies hold great potential for cardiac surgeons and their patients worldwide. These new anastomotic technologies will address a major clinical need in the field of surgical vascularization. Historically, this process has been the most difficult, time-consuming, and critical part of the bypass procedure.